首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   5772篇
  免费   614篇
  国内免费   12篇
耳鼻咽喉   48篇
儿科学   178篇
妇产科学   154篇
基础医学   808篇
口腔科学   48篇
临床医学   575篇
内科学   1335篇
皮肤病学   177篇
神经病学   429篇
特种医学   466篇
外科学   676篇
综合类   91篇
一般理论   2篇
预防医学   436篇
眼科学   78篇
药学   200篇
中国医学   9篇
肿瘤学   688篇
  2022年   30篇
  2021年   94篇
  2020年   55篇
  2019年   97篇
  2018年   72篇
  2017年   92篇
  2016年   77篇
  2015年   111篇
  2014年   169篇
  2013年   204篇
  2012年   255篇
  2011年   263篇
  2010年   179篇
  2009年   192篇
  2008年   212篇
  2007年   256篇
  2006年   246篇
  2005年   236篇
  2004年   251篇
  2003年   231篇
  2002年   213篇
  2001年   208篇
  2000年   215篇
  1999年   166篇
  1998年   149篇
  1997年   100篇
  1996年   107篇
  1995年   75篇
  1994年   81篇
  1993年   85篇
  1992年   123篇
  1991年   115篇
  1990年   103篇
  1989年   141篇
  1988年   124篇
  1987年   112篇
  1986年   119篇
  1985年   83篇
  1984年   75篇
  1983年   72篇
  1982年   63篇
  1981年   44篇
  1980年   40篇
  1979年   53篇
  1978年   48篇
  1977年   35篇
  1976年   36篇
  1975年   47篇
  1974年   33篇
  1973年   27篇
排序方式: 共有6398条查询结果,搜索用时 46 毫秒
1.
2.
3.
4.
5.
BACKGROUND: Despite different available methods for colorectal cancer (CRC) screening and their proven benefits, morbidity, and mortality of this malignancy are still high, partly due to low compliance with screening. Minimally invasive tests based on the analysis of blood specimens may overcome this problem. The purpose of this review was to give an overview of published studies on blood markers aimed at the early detection of CRC and to summarize their performance characteristics. METHOD: The PUBMED database was searched for relevant studies published until June 2006. Only studies with more than 20 cases and more than 20 controls were included. Information on the markers under study, on the underlying study populations, and on performance characteristics was extracted. Special attention was given to performance characteristics by tumor stage. RESULTS: Overall, 93 studies evaluating 70 different markers were included. Most studies were done on protein markers, but DNA markers and RNA markers were also investigated. Performance characteristics varied widely between different markers, but also between different studies using the same marker. Promising results were reported for some novel assays, e.g., assays based on SELDI-TOF MS or MALDI-TOF MS, for some proteins (e.g., soluble CD26 and bone sialoprotein) and also for some genetic assays (e.g., L6 mRNA), but evidence thus far is restricted to single studies with limited sample size and without further external validation. CONCLUSIONS: Larger prospective studies using study populations representing a screening population are needed to verify promising results. In addition, future studies should pay increased attention to the potential of detecting precursor lesions.  相似文献   
6.
In an era of ongoing improvement in cancer patient survival, available long-term survival figures from cancer registries are often outdated and too pessimistic for two reasons: first, delay in availability of cancer registry data, typically in the order of a few years, and, second, application of cohort-based methods of survival analysis, which provide survival estimates for patients diagnosed many years ago. We developed a model-based period analysis approach aimed to overcome both problems. We provide extensive empirical evaluation of our approach by comparing its performance with that of previously available methods for monitoring of 5- and 10-year relative survival, with the use of data from the nationwide Finnish Cancer Registry of 490,279 patients ages >/=15 years and diagnosed with one of 20 common forms of cancer between 1953 and 1997. We show that, in most cases, the model-based approach predicts 5- and 10-year relative survival expectations of newly diagnosed patients quite closely and much better than any of the previously available methods, including standard period analysis. We conclude that the model-based approach may enable deriving up-to-date cancer survival rates even with the common latency in availability of cancer registry data.  相似文献   
7.
A case of successful en bloc transplantation of a horseshoe kidney into a single recipient is reported. The literature is briefly reviewed. The use of horseshoe kidneys in transplantation is recommended in selected cases.  相似文献   
8.
Retrospectively we analyzed the histocompatibility data and clinical results of bone marrow transplantation in 51 patients who received marrow from unrelated donors (UD) from 1977 to 1987 at one of four UK BMT centers. We compared the results with those obtained in 51 transplants carried out at the same centers using HLA-identical (ID) sibling donors. Of the UD/recipient pairs 32 (63%) were serologically identical for HLA A, B, and DR antigens, and 37% showed varying degrees of mismatch. UD-BMT primary diagnoses were: severe aplastic anemia or Fanconi's anemia (n = 17), acute leukemia (n = 11), chronic myeloid leukemia (n = 21), and other conditions (n = 2). T cell depletion of the graft was associated with a significant improvement in survival in both UD and ID-BMT. Graft failure was more common in recipients of UD than of ID transplants (13 [25%] vs. 5 [10%] P = 0.05) but there was no significant difference in the frequency of acute or chronic graft-versus-host disease. Actuarial survival was superior for recipients of ID transplants (UD vs. ID: 49% vs. 78%, respectively, at 3 months; 32% vs. 63% at one year). Reduced survival for recipients of UD-BMT was confirmed in case control regression analysis (relative risk 3.0, P = 0.01). Nevertheless in patients whose only alternative is a partially mismatched family donor we think that UD-BMT is justified.  相似文献   
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号